Cargando…

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa

During door-to-door surveys in onchocerciasis-endemic regions in Africa, the age-specific ivermectin coverage in 29 722 individuals was assessed. Children 5–6 y of age had significantly lower coverage compared with older participants. Insufficient ivermectin intake among young children could prolong...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siewe Fodjo, J N, Mubiru, F, Ukaga, C, Logora, M Y, Mmbando, B P, Mandro, M, Njamnshi, A K, Colebunders, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964214/ https://www.ncbi.nlm.nih.gov/pubmed/31251354 http://dx.doi.org/10.1093/inthealth/ihz044

Ejemplares similares

High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey
por: Raimon, Stephen, et al.
Publicado: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey
por: Jada, Stephen Raimon, et al.
Publicado: (2022)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
por: O’Neill, Sarah, et al.
Publicado: (2019)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania
por: Bhwana, Dan, et al.
Publicado: (2022)

Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2020)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo
por: Dusabimana, Alfred, et al.
Publicado: (2021)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
por: Gumisiriza, Nolbert, et al.
Publicado: (2020)

The onchocerciasis hypothesis of nodding syndrome
por: Colebunders, Robert, et al.
Publicado: (2023)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
por: Mandro, Michel, et al.
Publicado: (2020)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
por: Abd-Elfarag, Gasim, et al.
Publicado: (2018)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
por: Dolo, Housseini, et al.
Publicado: (2018)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings
por: Morin, Alexandre, et al.
Publicado: (2021)

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness
por: Bhattacharyya, Samit, et al.
Publicado: (2023)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
por: Mmbando, Bruno P., et al.
Publicado: (2018)

Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon
por: Ngarka, Leonard, et al.
Publicado: (2023)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
por: Amuyunzu-Nyamongo, Mary, et al.
Publicado: (2011)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2022)

Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years
por: Greter, Helena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rkh2fku8lcjirch8gncng0rqs3